Likewise, in PEO1 ovarian cancer cells, PTEN knockdown activated Src kinase and increased EphA2 expression, whereas inhibiting Src with dasatinib potently suppressed Src phosphorylation and reduced EphA2 expression (Fig. 7H). This evidence concerns the gene PTEN and ovarian cancer.